Status | Study |
Active, not recruiting |
Study Name: Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Condition: Pancreatic Gastrinoma Pancreatic Neuroendocrine Tumor G1 Date: 2010-10-27 Interventions: Biological: Bevacizumab Given |
Active, not recruiting |
Study Name: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Condition: Adult Hepatocellular Carcinoma Advanced Adult Hepatocellular Carcinoma Date: 2009-11-06 Interventions: Biological: Bevacizumab Given |
Active, not recruiting |
Study Name: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors Condition: Gastrinoma Glucagonoma Insuli Date: 2008-04-09 Interventions: Drug: everolimus Given orally |
Completed |
Study Name: Treatment of Zollinger-Ellison Syndrome With Prevacid Condition: Zollinger-Ellison Syndrome Multiple Endocrine Neoplasia Date: 2005-09-13 Interventions: Drug: Lansoprazole (Prevacid) Lansoprazole 30mg capsules. dose is individualized to each subject based o |
Completed |
Study Name: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insuli Date: 2005-08-16 Interventions: Drug: sorafenib tosylate 400 mg given orally Other N |
Terminated |
Study Name: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insuli Date: 2004-06-10 Interventions: Drug: romidepsin Given IV |
Completed |
Study Name: Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome Condition: Zollinger-Ellison Syndrome Date: 2004-03-16 Interventions: Drug: Esomeprazole magnesium (Nexium) |
Completed |
Study Name: Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insuli Date: 2004-01-09 Interventions: Drug: gefitinib Given orally |
Completed |
Study Name: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu Condition: Advanced Adult Primary Liver Cancer Anaplastic Thyroid Cancer Date: 1999-12-10 Interventions: Biological: recombinant interleukin-12 |
Completed |
Study Name: Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome Condition: Gastrinoma Zollinger Ellison Syndrome Date: 1999-11-03 |